GO-SPAS MAX TABLET

GO-SPAS MAX TABLET	Mefenamic acid & Drotavarine Tablets

Composition :	Each film coated tablet contains Mefenamic Acid 250 mg & Drotavarine Hydrochloride 80 mg
Indications :	Primary & Secondary Dysmenorrhoea Post Surgical Uterine Spasm Uterine irritability and pain associated with IUCD insertion, dilatation and curettage, Pelvic Inflammatory Disease or HSG Gastro-Intestinal Colic, Renal Colic, Biliary Colic
Contraindications :	Hypersensitivity to Mefenamic Acid, Drotavarine or excipients; severe renal or hepatic failure; severe cardiac insufficiency (low output syndrome) and heart failure; children under 1-year old; inflammatory bowel disease, history of gastrointestinal bleeding or perforation related to previous NSAIDs therapy.
Adverse Effects :	Mefenamic acid: Peptic Ulcers, perforation or GI bleeding, sometimes fatal, dyspepsia, abdominal pain, melaena, hematemesis, ulcerative stomatitis, exacerbation of colitis and Crohn’s disease). Drotavarine: Rare (≥ 0.01 and <0.1%) palpitations, hypotension, headache, vertigo, insomnia, nausea, constipation, allergic reaction (Angioedema, Urticaria, Rash, Pruritus).
Dosage :	The usual dose of Go-Spas Max tablet is one tablet twice daily.